Viewing Study NCT01568892


Ignite Creation Date: 2025-12-24 @ 3:14 PM
Ignite Modification Date: 2026-01-04 @ 6:38 AM
Study NCT ID: NCT01568892
Status: COMPLETED
Last Update Posted: 2018-07-02
First Post: 2012-03-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir
Sponsor: ViiV Healthcare
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-04-18
Start Date Type: ACTUAL
Primary Completion Date: 2012-10-31
Primary Completion Date Type: ACTUAL
Completion Date: 2013-12-16
Completion Date Type: ACTUAL
First Submit Date: 2012-03-29
First Submit QC Date: None
Study First Post Date: 2012-04-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2013-08-15
Results First Submit QC Date: None
Results First Post Date: 2014-02-19
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-06-14
Last Update Post Date: 2018-07-02
Last Update Post Date Type: ACTUAL